Issue #42June 22, 20268 studies

Blood proteins from 60,542 people suggest 1-in-4 are aging faster in at least one cell type

This week's research paints a detailed picture of how aging works at the cellular level — and why two people the same age can be on very different biological trajectories. From blood proteins that predict disease 15 years out, to engineered immune cells that clear aging cells, to a drug that extends lifespan in two different species, there's a lot to dig into.

🧬 A Blood Test That Reads 40+ Cell Types' Biological Ages — And Predicts Disease

A study analyzing 7,000+ plasma proteins from 60,542 individuals built machine learning models to estimate biological age across more than 40 cell types — from neurons to immune cells to muscle.

Here's what they found:

20–25% of people showed accelerated aging in at least one cell type; 1–3% showed it in 10 or more cell types simultaneously.
People with two copies of the APOE4 gene (a major Alzheimer's risk gene) had older-appearing astrocytes (brain support cells) but younger-appearing macrophages (immune cells) compared to APOE3 carriers — and extreme astrocyte aging was linked to triple the risk of Alzheimer's disease in that group.
Extremely aged skeletal muscle cells were associated with a 12.7-fold higher risk of ALS (a progressive nerve disease), and in smokers, extreme aging of respiratory epithelial cells (lung lining cells) was linked to 58% higher lung cancer risk compared to smoking alone.

Why it matters: This suggests that aging isn't uniform across the body — different cell types age at different rates in different people, and those differences appear linked to specific disease risks up to 15 years later. A single 'biological age' number may miss most of what's happening.

🔗 Nature medicine Journal Article 🗓️ Jun 15

Key Findings

💉 Senolytic Drugs Work Better When Started Early in Mice

Dasatinib + quercetin (D+Q), a widely studied senolytic drug combo (drugs that selectively clear aging cells), was tested across multiple tissues in aged mice using single-cell analysis.
D+Q appeared to enhance immune cell function, reduce tissue inflammation, and improve metabolic profiles — but the effects were tissue- and cell-type-specific, not uniform.
Mice that started treatment during early aging and received longer treatment showed a greater tendency toward reduced aging markers than those who started late with shorter treatment.

💡 Timing and duration may matter for senolytic interventions — early and sustained treatment could point to better outcomes, at least in mice.

🥇 Top 1% journal 🔗 Nature aging Journal Article 🗓️ Jun 17

🔬 A Protein Called ZNF512B May Suppress Aging-Related Inflammation

Using a CRISPR screen (a tool to test thousands of genes systematically), researchers identified ZNF512B as a suppressor of the SASP — the inflammatory signals that aging cells release and that drive tissue damage.
When ZNF512B was lost, DNA damage accumulated and inflammatory signaling (via the cGAS-STING pathway) was activated.
In human neuromuscular organoids (lab-grown mini tissue models), ZNF512B deficiency produced inflammation and cytokine patterns resembling ALS.
In mice with acute liver injury, overexpressing ZNF512B reduced DNA damage and inflammation markers.

💡 ZNF512B may represent a regulatory checkpoint that limits aging-related inflammation — its loss appears linked to patterns seen in neurodegenerative disease.

🥇 Top 1% journal 🔗 Cell stem cell Journal Article 🗓️ Jun 16

🦋 Tropical Butterflies Live 3x Longer Than Their Relatives — And Age More Slowly

Heliconius butterflies show a roughly 3-fold lifespan extension compared to close relatives in the same tribe, with some species living nearly a year.
Captive experiments suggest this extended lifespan is accompanied by slowed physiological aging — not just delayed death.
Data were gathered from commercial butterfly houses, mark-release-recapture studies, and insectary populations, providing multiple lines of evidence.

💡 Heliconius butterflies could serve as a model for studying the biological mechanisms behind extended, healthier lifespans in animals.

🥈 Top 2% journal 🔗 Nature communications Journal Article 🗓️ Jun 16

🧪 Fluspirilene Extended Lifespan in Both Flies and Worms

A cell-based screen designed to find compounds that mimic dietary restriction identified fluspirilene (an antipsychotic drug) as a candidate that selectively boosts translation of short-mRNA proteins — a pattern associated with longevity.
Fluspirilene significantly extended lifespan in both Drosophila melanogaster (fruit flies) and Caenorhabditis elegans (roundworms), and reduced age-related movement decline in female flies.
Its lifespan effects in worms required DAF-16/FOXO and HLH-30/TFEB (two key longevity-related transcription factors) and the autophagy gene atg-18.
Fluspirilene failed to extend lifespan in two other Caenorhabditis species or in flies on a high-yeast diet, indicating its effects depend on evolutionary context and nutrient conditions.

💡 Fluspirilene's lifespan effects in two different model organisms suggest that modulating protein translation could be a viable strategy for healthy aging research — though effects appear context-dependent.

🔗 J Gerontol A Biol Sci Med Sci Journal Article 🗓️ Jun 19

🏃 Older Adults Who Walk Fast Have Half the Risk of Cognitive Decline

Across 3,989 adults aged 80+ from 5 international studies, 'super movers' (those with gait speeds ≥1.5 standard deviations above age-adjusted averages) had a 49% lower risk of developing cognitive impairment over 3.4–5.4 years of follow-up.
In a separate cohort of 197 adults (average age 84.6), super movers showed slower decline in both memory and non-memory cognitive domains, plus preserved hippocampal volume (the brain's memory hub) in specific subregions.
In 692 participants from a third cohort, super movers had better cognitive function before death and lower Alzheimer's and dementia prevalence — but no differences in brain pathology found after death.

💡 Faster walking speed at 80+ is associated with substantially lower cognitive impairment risk — though whether the relationship is causal or reflects shared underlying health remains unclear.

🥉 Top 5% journal 🔗 Neurology Comparative Study 🗓️ Jun 16

⚖️ Weight-Loss Surgery Linked to ~5.5-Year Reduction in Biological Age

In 505 patients who underwent bariatric surgery, biological age (estimated from blood markers linked to mortality risk) dropped by an average of 5.55 years at 12 months post-surgery — and remained stable through 24 months.
When adjusted for changes in body mass index over time, the biological age reduction was 3.32 years, suggesting some of the effect is independent of weight loss itself.
The effect was more pronounced in men, and was associated with a 40–50% reduction in expected mortality over two years.

💡 Biological age may provide a more sensitive measure of health gain after bariatric surgery than weight loss alone — though this is an observational study and causation cannot be confirmed.

🥉 Top 5% journal 🔗 npj aging Journal Article 🗓️ Jun 18

🦠 Nanoplastics Linked to Signs of Accelerated Aging in Young Mice

Young mice (8 weeks old) exposed to 1,000 μg/L of polystyrene nanoplastics showed significantly elevated levels of p21 and p16 (two key cellular aging markers) in lung and liver tissue.
Inflammatory cytokines — IL-1β, IL-6, and TNF-α — were also elevated, apparently via the p38 MAPK signaling pathway.
16S rRNA sequencing revealed that nanoplastic exposure disrupted both oral and gut microbiota diversity and community structure.
Antioxidant gene expression decreased in exposed animals.

💡 In mice, nanoplastic exposure at relatively high concentrations appears linked to early signs of cellular aging and microbiome disruption — whether these findings translate to human exposure levels remains to be studied.

🥉 Top 5% journal 🔗 Frontiers in immunology Journal Article 🗓️ Jun 15

Implications

Taken together, this week's research suggests aging is far more heterogeneous — and measurable — than previously appreciated. Cell-type-specific aging signatures in blood, tissue-level markers like nuclear size, and composite biological age scores all point toward a future where 'how old you are' is less a single number and more a profile. The flip side: interventions — whether senolytics, surgery, or novel compounds like fluspirilene — may need to be matched to the right timing, tissue, and individual context to be effective.

Studies in this issue

Primary sources used for this newsletter.

Blood protein patterns linked to cell aging that may predict human diseases
main storyNature medicine2026-06-15PMID 42297981
Biological age linked to death risk improves after weight-loss surgery, even without losing weight
key findingnpj aging2026-06-18PMID 42315524
Longer lifespan and slower ageing in a group of tropical butterflies
key findingNature communications2026-06-16PMID 42303607
Senolytic treatment in old mice may change immune, scar tissue, and metabolism functions
key findingNature aging2026-06-17PMID 42310394
ZNF512B protects genetic control areas to reduce aging-related inflammation
key findingCell stem cell2026-06-16PMID 42302791
Cognitive Aging and Brain Health Differences Between Highly Active and Less Active Older Adults
key findingNeurology2026-06-16PMID 42302219
Cell-based screen finds protein-making regulators that may extend lifespan in fruit flies and worms
key findingThe journals of gerontology. Series A, Biological sciences and medical sciences2026-06-19PMID 42320027
Polystyrene Nanoplastics May Cause Inflammation and Aging in Young Mice Through Changes in the Gut Microbiome
key findingFrontiers in immunology2026-06-15PMID 42292417